Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment

J Thorac Oncol. 2018 Aug;13(8):e143-e145. doi: 10.1016/j.jtho.2018.03.015.

¹ Oncology Division, Azienda Sanitaria Locale 5 Spezzino, La Spezia, Italy.
² Tumor Epigenetics Unit, Ospedale Policlinico San Martino, Genoa, Italy.
³ Clinical Epidemiology Unit, Ospedale Policlinico San Martino, Genoa, Italy.
⁴ Radiodiagnostic Division, Azienda Sanitaria Locale 5 Spezzino, La Spezia, Italy.
⁵ Pneumology Division, Azienda Sanitaria Locale 5 Spezzino, La Spezia, Italy.
⁶ Medicine Division, Azienda Sanitaria Locale 5 Spezzino, La Spezia, Italy.
⁷ Histopathology and Cytopathology Division, Azienda Sanitaria Locale 5 Spezzino, La Spezia, Italy.
⁸ Histopathology and Cytopathology Division, Azienda Sanitaria Locale 5 Spezzino, La Spezia, Italy. Electronic address: silvio.roncella@asl5.liguria.it.

No abstract available

Publication types